TY - JOUR
T1 - Lipid-soluble Cigarette Smoke Particles Induced Vascular Endothelin Type A Receptor Up-Regulation through Activation of ERK1/2 Signal Pathways
AU - Zhang, Yaping
AU - Zhang, Wei
AU - Edvinsson, Lars
AU - Xu, Cang-Bao
N1 - This article is protected by copyright. All rights reserved.
PY - 2017
Y1 - 2017
N2 - Abnormal contraction of vessels termed "vasospasm" is associated with various cardiovascular diseases. Smoking is a well-known risk factor that increases vasospasm. However, the molecular mechanisms by which smoking leads to vasospasm and cardiovascular disease are not fully understood. The present study was designed to examine if DMSO-extracted cigarette smoke particles (DSP) could induce up-regulation of vascular endothelin type A (ETA ) receptors, and if ETA receptor is up-regulated through activation of extracellular regulated protein kinase 1 and 2 (ERK1/2) signal pathways. Mesenteric arterial segments from rats were cultured in the presence of DSP, water-extracted cigarette smoke particles (WSP), or equivalent concentration of nicotine for up to 24 hr. The results showed that DSP, but not WSP or nicotine, induced ETA receptor up-regulation with increased ETA receptor-mediated contraction (myograph, P<0.001). Simultaneously, the expression of ETA receptor mRNA (real-time PCR, P<0.001) and protein (immunohistochemistry) were enhanced in the smooth muscle cells, suggesting that the lipid-soluble substances contained in cigarette smoke were responsible for the effects of DSP. Actinomycin D (a general transcriptional inhibitor) decreased ETA receptor mRNA expression and attenuated receptor-mediated contraction (P<0.001), while DSP accelerated ETA receptor mRNA degradation (P<0.01) and promoted the translation of ETA receptor mRNA into protein. Furthermore, the up-regulation of ETA receptors was significantly attenuated by inhibition of ERK1/2 signal pathways (P<0.001). In conclusion, DSP most likely activate ERK1/2 signal pathways-mediated transcriptional and post-transcriptional (translational) mechanisms that lead to vascular ETA receptor up-regulation, which might contribute to vasospasm and the development of smoking-associated cardiovascular diseases. This article is protected by copyright. All rights reserved.
AB - Abnormal contraction of vessels termed "vasospasm" is associated with various cardiovascular diseases. Smoking is a well-known risk factor that increases vasospasm. However, the molecular mechanisms by which smoking leads to vasospasm and cardiovascular disease are not fully understood. The present study was designed to examine if DMSO-extracted cigarette smoke particles (DSP) could induce up-regulation of vascular endothelin type A (ETA ) receptors, and if ETA receptor is up-regulated through activation of extracellular regulated protein kinase 1 and 2 (ERK1/2) signal pathways. Mesenteric arterial segments from rats were cultured in the presence of DSP, water-extracted cigarette smoke particles (WSP), or equivalent concentration of nicotine for up to 24 hr. The results showed that DSP, but not WSP or nicotine, induced ETA receptor up-regulation with increased ETA receptor-mediated contraction (myograph, P<0.001). Simultaneously, the expression of ETA receptor mRNA (real-time PCR, P<0.001) and protein (immunohistochemistry) were enhanced in the smooth muscle cells, suggesting that the lipid-soluble substances contained in cigarette smoke were responsible for the effects of DSP. Actinomycin D (a general transcriptional inhibitor) decreased ETA receptor mRNA expression and attenuated receptor-mediated contraction (P<0.001), while DSP accelerated ETA receptor mRNA degradation (P<0.01) and promoted the translation of ETA receptor mRNA into protein. Furthermore, the up-regulation of ETA receptors was significantly attenuated by inhibition of ERK1/2 signal pathways (P<0.001). In conclusion, DSP most likely activate ERK1/2 signal pathways-mediated transcriptional and post-transcriptional (translational) mechanisms that lead to vascular ETA receptor up-regulation, which might contribute to vasospasm and the development of smoking-associated cardiovascular diseases. This article is protected by copyright. All rights reserved.
U2 - 10.1111/bcpt.12688
DO - 10.1111/bcpt.12688
M3 - Journal article
C2 - 27731935
SN - 1742-7843
VL - 120
SP - 327
EP - 334
JO - Basic & clinical pharmacology & toxicology
JF - Basic & clinical pharmacology & toxicology
IS - 4
ER -